PAWZ - ETF AI Analysis
Top Page
ProShares Pet Care ETF (PAWZ)
PAWZ, the ProShares Pet Care ETF, earns a solid overall rating thanks to strong, diversified holdings like Idexx Laboratories, Zoetis, Virbac, Merck, and Nestlé, which combine robust financial performance, growth potential, and generally positive technical or valuation profiles. However, names like Chewy and Pet Valu introduce some drag due to bearish technical trends, high valuations, and leverage-related concerns, making sector concentration in pet care and related consumer businesses the main risk factor if market conditions turn against this niche.
PAWZ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 33.13M
- Region
- Global
- Expense Ratio
- 0.50%
- Beta
- 0.61
- Issuer
- ProShares
- Inception Date
- Nov 05, 2018
- Dividend Yield
- 0.71%
- Asset Class
- Equity
- Index Tracked
- FactSet Pet Care Index
PAWZ Summary
PAWZ is the ProShares Pet Care ETF, built to follow the FactSet Pet Care Index, a theme focused on the global pet care industry. It owns companies involved in pet food, vet services, pet medicine, and specialty pet retailers. Well-known holdings include Chewy, Zoetis, Merck, and Nestlé. Someone might invest in PAWZ to tap into long-term growth as people spend more on their pets and treat them like family, while also getting diversification across many pet-related businesses. A key risk is that it’s concentrated in the pet care sector, so its price can rise or fall sharply with trends in that industry and the overall stock market.
How much will it cost me?
The ProShares Pet Care ETF (PAWZ) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on a niche sector, which typically requires more specialized research and management.
What would affect this ETF?
The ProShares Pet Care ETF could benefit from rising global pet ownership and increased spending on pet health and wellness, as pets are increasingly treated as family members. However, economic downturns or higher interest rates could negatively impact consumer spending on non-essential pet products and services, and regulatory changes in the healthcare sector might affect key holdings like Idexx Laboratories and Zoetis. The ETF’s global exposure also makes it sensitive to international market conditions and currency fluctuations.
PAWZ Top 10 Holdings
PAWZ is heavily tilted toward pet health and retail, with Idexx Laboratories and Zoetis setting the tone but currently lagging, which has been a headwind for the fund. Chewy and Pet Valu add more retail flavor, yet their mixed, generally weak momentum suggests the online and specialty pet store story is losing steam for now. On the brighter side, Merck and Oil-Dri of America are quietly pulling their weight, offering steadier support. With a global mix spanning the U.S., Europe, and Canada, PAWZ is a focused bet on the worldwide pet care boom, even if some stars are temporarily out of stride.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 IDXX | Idexx Laboratories | 10.55% | $3.50M | $44.15B | -12.08% | 78Outperform |
 ZTS | Zoetis | 10.34% | $3.43M | $32.80B | -44.59% | 74Outperform |
 FRPT | Freshpet | 9.93% | $3.30M | $3.20B | 24.19% | 66Neutral |
 CHWY | Chewy | 9.75% | $3.23M | $8.43B | -44.98% | 54Neutral |
 FR:VIRP | Virbac SA | 7.46% | $2.48M | EUR 2.82B | 8.36% | 75Outperform |
 TRUP | Trupanion | 4.84% | $1.60M | $1.23B | -33.76% | 69Neutral |
 TSE:PET | Pet Valu Holdings Ltd. | 4.59% | $1.52M | CAD 1.32B | -43.82% | 65Neutral |
 GB:PETS | Pets at Home | 4.48% | $1.49M | GBP 953.73M | 2.78% | 74Outperform |
 CH:NESN | Nestlé SA | 4.50% | $1.49M | CHF 212.03B | -0.94% | 71Outperform |
 MRK | Merck & Company | 4.34% | $1.44M | $360.08B | 73.92% | 80Outperform |
PAWZ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAWZ, the sentiment is Positive. The current price of 50.86 is above the 20-day moving average (MA) of 48.05, above the 50-day MA of 49.99, and below the 200-day MA of 51.02, indicating a neutral trend. The MACD of 0.16 indicates Negative momentum. The RSI at 67.86 is Neutral, neither overbought nor oversold. The STOCH value of 93.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAWZ.
PAWZ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PAWZ | $50.86 | $55.00(8.14% Upside) | $33.13M | 0.50% | 67Neutral |
 DRNZ | $16.84 | $31.18(85.15% Upside) | $97.02M | 0.65% | 51Neutral |
 LOGO | $20.09 | $25.08(24.86% Upside) | $33.17M | 0.69% | 73Outperform |
 OND | $33.32 | $44.84(34.56% Upside) | $2.49M | 0.58% | 57Neutral |
 YUNG | $27.35 | $33.59(22.79% Upside) | $966.43K | 0.35% | 66Neutral |
 STYL | $25.23 | $30.47(20.78% Upside) | $382.41K | 0.35% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PAWZ | ProShares Pet Care ETF | 50.86 | -5.32 | -9.46% | |
| DRNZ | REX Drone ETF | 16.84 | -7.59 | -31.08% | |
| LOGO | Tidal Trust III Alpha Brands Consumption Leaders ETF | 20.09 | -1.51 | -6.97% | |
| OND | ProShares On-Demand ETF | 33.32 | -13.28 | -28.50% | |
| YUNG | Corgi Longevity Consumer ETF | 27.35 | 1.66 | 6.46% | |
| STYL | Corgi Lifestyle Brands ETF | 25.23 | -0.80 | -3.06% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.